Inflammation-related biomarkers as predictors of pathological complete response in early-stage breast cancer.

Background: Neoadjuvant systemic therapy (NAT) represents an attractive option for improved outcomes of early-stage breast cancer (BC) patients, as it can significantly reduce tumor burden thus permitting breast-conserving resections. Equally important, the eradication of viable cancer cells post-NAT, also known as pathological complete response (pCR), has emerged as a strong prognostic biomarker, reflecting tumor's biology and subsequent treatment responses. Yet to date, no validated markers predictive of pCR have been identified.

Juno Observations Set New Constraints on the Electrodynamic Interaction Between Io and Jupiter.

Juno's highly elliptical polar orbits provide unprecedented in-situ observations of the electrodynamic interaction between Jupiter and its volcanic moon Io. These observations occur in regions never sampled before both near Io's orbit and near Jupiter's ionosphere and at distances between the two. Magnetic field data obtained during multiple traversals of magnetic field lines mapping to Io's orbit reveal remarkably rich and complex magnetic signatures near flux tubes connected to Io's orbital position.

Cardiovascular and All-Cause Mortality Is Affected by Serum Magnesium and Diet Pattern in a Cohort of Dialysis Patients.

Hypomagnesaemia is associated with an increased overall mortality in patients with chronic kidney disease on dialysis (CKD-5D). Mediterranean-style diet (MD), having a high magnesium content, can serve as a form of dietary magnesium supplementation. We examined whether there is a potential link between increased Mediterranean Diet score (MDS) and elevated serum magnesium (sMg) to assess its impact on reducing mortality risk in CKD-5D patients.

ES-SCLC Patients with PD-L1 CTCs and High Percentages of CD8PD-1T Cells in Circulation Benefit from Front-Line Immunotherapy Treatment.

SCLC is an aggressive cancer type with high metastatic potential and bad prognosis. CTCs are a valuable source of tumor cells in blood circulation and are among the major contributors to metastasis. In this study we evaluated the number of CTCs that express PD-L1 in treatment-naïve ES-SCLC patients receiving ICI in a front-line setting.